Download presentation
Presentation is loading. Please wait.
Published byHarvey Carson Modified over 9 years ago
1
Naomi Sen
2
Aim ◦ To give an outline of the diagnosis and management of SLE Objectives ◦ To describe signs and symptoms of SLE ◦ To outline relevant investigations ◦ To describe management of SLE
3
Pathogenesis Epidemiology and risk factors Presentation Investigations Associated illnesses Management Pregnancy and fertility Prognosis Summary
4
SLE is a heterogeneous, inflammatory, multisystem autoimmune disease in which antinuclear antibodies occur.
5
Failure to clear apopetic material efficiently Anti-Ro and Anti–La widespread vasculitis
7
Prevalence : 50-100/100000 Peak onset 20-40y Female : Male 9:1 Chinese, Southeast Asian (1 in 1000) and Afro-Caribbean (1 in 500) most common Least common in Northern European origin (1 in 2800)
8
Genetic ◦ HLA-B8 and DR3 in caucasians, (DR2 in Japanese) Complement ◦ Defective C4 gene Environmental ◦ EBV ◦ UV light ◦ Drugs: ChlorpromazineIsoniazid Methyldopad-penicillamine HyrdalazineMinocycline
10
Relapsing and remitting Non-specific ◦ Fatigue ◦ Malaise ◦ Arthralgia ◦ Lymphadenopathy ◦ Fever
11
Joints and Muscles ◦ Most common clinical feature ◦ Symmetrical small joint arthralgia Clinically normal examination Skin ◦ Butterfly erythema ◦ Vasculitic lesions on fingertips and nail folds ◦ Purpura and urticaria ◦ 1/3 - photosensitivity
12
Lungs ◦ Pleurisy ◦ Recurrent pleural effusions (exudate) Cardiovascular ◦ Pericarditis ◦ Mild myocarditis =/- arrhythmias ◦ Raynaud’s ◦ Arterial and venous thromboembolism – antiphospholipid syndrome ◦ Atherosclerotic disease
13
Kidneys ◦ glomerulonephritis CNS ◦ Depression ◦ Epilepsy ◦ Migraine ◦ Hemiplegia ◦ Ataxia ◦ Psychosis ◦ Demyelinating syndromes
14
Eyes ◦ Retinal vasculitis hard exudates and haemorrhages ◦ Episcleritis/conjunctivitis/optic neuritis GI ◦ Mouth ulcers ◦ Abdominal pain – mesenteric vasculitis inflammation perforation or infarction
15
DOPAMINE RASH – 4 out of 11 ◦ Discoid Rash ◦ Oral Ulcers ◦ Photosensitivity ◦ Arthritis ◦ Malar rash ◦ Immunological – anti ro, la, smith, dsDNA ◦ Neurological changes ◦ Elevated ESR ◦ Renal involvement ◦ ANA +ve ◦ Serositis (plurisy and pericarditis) ◦ Haematological (haemolytic anaemia, ↓WCC↓plt)
16
Bloods ◦ FBC Leucopenia/ Lymphopenia Thrombocytopenia Anameia –AI haemolysis ◦ ESR Raised, CRP normal ◦ ANA Positive ◦ RF +ve – 25% ◦ Complement levels Reduced ◦ Antiphospholipid antibodies Anticardiolipn Anti B2-glycoprotein Lupus anticoagulant ◦ Immunoglobulins Raised Polyclonal IgG and IgM
17
Histology ◦ Skin biopsies ◦ Renal biopsies Imaging ◦ CT ◦ MRI
18
Antiphospholipid syndrome Overlap syndromes: scleroderma, polymyositis, rheumatoid arthritis and Sjögren's syndrome Prone to other autoimmune conditions such as thyroiditis Higher incidence of drug allergy Increased risk of infection Increased risk atherosclerosis, hypertension, dyslipidaemias, diabetes, osteoporosis, avascular necrosis and malignancies (especially non- Hodgkin's lymphoma)
19
Individual counselling Avoid sun exposure, use sunscreen Analgesia – caution with NSAIDs Corticosteroids – effecitive – but s/e Hydroxychloroquine Cyclphosphamide – life threatening Azothioprine – steroid sparing Methotrexate
20
Barrier methods of contraception -safest Oestrogens can exacerbate lupus Lowest dose COCP can be used with caution if no ◦ Migraines ◦ Thrombosis ◦ Hypertension ◦ Anticardiolipin antibodies are negative Increased risk of thrombosis – needs to be counselled.
21
Fertility is normal Pregnancy is safe in mild or stable disease In severe lupus – disease should be controlled prior to pregnancy Morbidity - ↑if antiphospholipid antibodies ◦ Recurrent miscarriage ◦ Pre-eclampsia ◦ IUGR ◦ Premature delivery ◦ Thrombosis ◦ Worsening or renal disease and hypertension LMWH and low dose aspirin treatment of choice
22
Improved with earlier recognition and improved management. ◦ Morbidity and mortality – higher in patients with extensive multisystem disease and multiple auto antibodies ◦ Renal involvement poorer prognosis ◦ Drug induced lupus usually subsides when the drug is discontinued.
23
SLE is a heterogeneous, inflammatory, multisystem autoimmune disease in which antinuclear antibodies occur. More common in females in their 20-40s More common in Asian and Afro-Caribbean populations
24
Relapsing remitting Diagnosis – 4 out of 11 “DOPAMINE RASH” Multiple systems – most common – joint pain Initial investigations – Bloods - FBC, ESR, CRP, Complement, ANA, RF, Immunoglobulins, Antiphospholipid antibodies
25
Management ◦ Individual ◦ Sunscreen ◦ Analgesia ◦ Steroids and immunosuppression if severe ◦ Contraception if severe Barrier – fewer risks than hormonal ◦ If antiphospholipid LMWH and aspirin in pregnancy
27
www.patient.co.uk www.patient.co.uk Kumar and Clarke Also Wikipedia and Dr Google!
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.